Allred Capital Management, LLC Gilead Sciences, Inc. Transaction History

Allred Capital Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 05, 2021	SELL	$63.47 - $69.35 $211,291 - $230,866	-3,329 Closed	0 $0
Q1 2021 May 06, 2021	SELL	$60.0 - $68.46 $35,400 - $40,391	-590 Reduced 15.05%	3,329 $215,000
Q4 2020 Jan 21, 2021	BUY	$56.65 - $64.55 $168,307 - $191,778	2,971 Added 313.4%	3,919 $228,000
Q1 2020 Apr 17, 2020	SELL	$62.63 - $80.22 $2,254 - $2,887	-36 Reduced 3.66%	948 $70.9 Million
Q4 2019 Jan 13, 2020	BUY	$61.62 - $67.78 $60,634 - $66,695	984 New	984 $63,000

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Allred Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Allred Capital Management, LLC with notifications on news.